Literature DB >> 24014022

Restoring the procofactor state of factor Va-like variants by complementation with B-domain peptides.

Matthew W Bunce1, Mettine H A Bos, Sriram Krishnaswamy, Rodney M Camire.   

Abstract

Coagulation factor V (FV) circulates as an inactive procofactor and is activated to FVa by proteolytic removal of a large inhibitory B-domain. Conserved basic and acidic sequences within the B-domain appear to play an important role in keeping FV as an inactive procofactor. Here, we utilized recombinant B-domain fragments to elucidate the mechanism of this FV autoinhibition. We show that a fragment encoding the basic region (BR) of the B-domain binds with high affinity to cofactor-like FV(a) variants that harbor an intact acidic region. Furthermore, the BR inhibits procoagulant function of the variants, thereby restoring the procofactor state. The BR competes with FXa for binding to FV(a), and limited proteolysis of the B-domain, specifically at Arg(1545), ablates BR binding to promote high affinity association between FVa and FXa. These results provide new insight into the mechanism by which the B-domain stabilizes FV as an inactive procofactor and reveal how limited proteolysis of FV progressively destabilizes key regulatory regions of the B-domain to produce an active form of the molecule.

Entities:  

Keywords:  Autoinhibition; Coagulation Factors; Enzyme Mechanisms; Factor V; Factor Va; Hemostasis; Protein Engineering; Prothrombinase; Recombinant Protein Expression

Mesh:

Substances:

Year:  2013        PMID: 24014022      PMCID: PMC3798483          DOI: 10.1074/jbc.M113.506840

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

1.  Studies on the structure of bovine factor V by scanning transmission electron microscopy.

Authors:  M W Mosesson; M E Nesheim; J DiOrio; J F Hainfeld; J S Wall; K G Mann
Journal:  Blood       Date:  1985-05       Impact factor: 22.113

2.  Complete cDNA and derived amino acid sequence of human factor V.

Authors:  R J Jenny; D D Pittman; J J Toole; R W Kriz; R A Aldape; R M Hewick; R J Kaufman; K G Mann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

3.  Kinetics of the inhibition of thrombin by hirudin.

Authors:  S R Stone; J Hofsteenge
Journal:  Biochemistry       Date:  1986-08-12       Impact factor: 3.162

4.  The interaction of bovine factor V and factor V-derived peptides with phospholipid vesicles.

Authors:  D L Higgins; K G Mann
Journal:  J Biol Chem       Date:  1983-05-25       Impact factor: 5.157

5.  Electron microscopy and hydrodynamic properties of blood clotting factor V and activation fragments of factor V with phospholipid vesicles.

Authors:  P D Lampe; M L Pusey; G J Wei; G L Nelsestuen
Journal:  J Biol Chem       Date:  1984-08-10       Impact factor: 5.157

6.  Characterization of Factor V activation intermediates.

Authors:  M E Nesheim; W B Foster; R Hewick; K G Mann
Journal:  J Biol Chem       Date:  1984-03-10       Impact factor: 5.157

7.  Structure of bovine blood coagulation factor Va. Determination of the subunit associations, molecular weights, and asymmetries by analytical ultracentrifugation.

Authors:  T M Laue; A E Johnson; C T Esmon; D A Yphantis
Journal:  Biochemistry       Date:  1984-03-27       Impact factor: 3.162

8.  The factor Xa-catalyzed activation of factor V.

Authors:  W B Foster; M E Nesheim; K G Mann
Journal:  J Biol Chem       Date:  1983-11-25       Impact factor: 5.157

9.  Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor.

Authors:  W F Novotny; T J Girard; J P Miletich; G J Broze
Journal:  Blood       Date:  1988-12       Impact factor: 22.113

10.  Prothrombinase complex assembly. Contributions of protein-protein and protein-membrane interactions toward complex formation.

Authors:  S Krishnaswamy
Journal:  J Biol Chem       Date:  1990-03-05       Impact factor: 5.157

View more
  15 in total

1.  Occlusion of anion-binding exosite 2 in meizothrombin explains its impaired ability to activate factor V.

Authors:  Harlan N Bradford; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2018-12-21       Impact factor: 5.157

2.  Platelets contain tissue factor pathway inhibitor-2 derived from megakaryocytes and inhibits fibrinolysis.

Authors:  Kanagasabai Vadivel; Sathya-Moorthy Ponnuraj; Yogesh Kumar; Anne K Zaiss; Matthew W Bunce; Rodney M Camire; Ling Wu; Denis Evseenko; Harvey R Herschman; Madhu S Bajaj; S Paul Bajaj
Journal:  J Biol Chem       Date:  2014-09-28       Impact factor: 5.157

3.  Circumventing furin enhances factor VIII biological activity and ameliorates bleeding phenotypes in hemophilia models.

Authors:  Joshua I Siner; Benjamin J Samelson-Jones; Julie M Crudele; Robert A French; Benjamin J Lee; Shanzhen Zhou; Elizabeth Merricks; Robin Raymer; Timothy C Nichols; Rodney M Camire; Valder R Arruda
Journal:  JCI Insight       Date:  2016-10-06

4.  Interaction of factor V B-domain acidic region with its basic region and with TFPI/TFPI2: Structural insights from molecular modeling studies.

Authors:  Kanagasabai Vadivel; Yogesh Kumar; Matthew W Bunce; Rodney M Camire; Madhu S Bajaj; S Paul Bajaj
Journal:  Int Biol Rev       Date:  2017-05

5.  Factor V east Texas variant causes bleeding in a three-generation family.

Authors:  Julie A Peterson; Sweta Gupta; Nicholas D Martinez; Brandon Hardesty; Susan A Maroney; Alan E Mast
Journal:  J Thromb Haemost       Date:  2021-12-07       Impact factor: 5.824

Review 6.  Biology of tissue factor pathway inhibitor.

Authors:  Jeremy P Wood; Paul E R Ellery; Susan A Maroney; Alan E Mast
Journal:  Blood       Date:  2014-03-11       Impact factor: 22.113

7.  TFPIα interacts with FVa and FXa to inhibit prothrombinase during the initiation of coagulation.

Authors:  Jeremy P Wood; Helle H Petersen; Bingke Yu; Xiaoai Wu; Ida Hilden; Alan E Mast
Journal:  Blood Adv       Date:  2017-12-26

8.  Reduced Prothrombinase Inhibition by Tissue Factor Pathway Inhibitor Contributes to the Factor V Leiden Hypercoagulable State.

Authors:  Jeremy P Wood; Lisa M Baumann Kreuziger; Paul E R Ellery; Susan A Maroney; Alan E Mast
Journal:  Blood Adv       Date:  2017-02-14

9.  Cryo-EM structure of the prothrombin-prothrombinase complex.

Authors:  Eliza A Ruben; Brock Summers; Michael J Rau; James A J Fitzpatrick; Enrico Di Cera
Journal:  Blood       Date:  2022-06-16       Impact factor: 25.476

10.  Cryo-EM structures of human coagulation factors V and Va.

Authors:  Eliza A Ruben; Michael J Rau; James A J Fitzpatrick; Enrico Di Cera
Journal:  Blood       Date:  2021-06-03       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.